Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giovanni.antonini@uniroma1.it
Giovanni Antonini
Professore Associato
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
giovanni.antonini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures
JOURNAL OF NEUROSURGICAL SCIENCES
2022
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score
NEUROLOGY
2022
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database
NEUROLOGICAL SCIENCES
2022
Benefit and danger from immunotherapy in myasthenia gravis
NEUROLOGICAL SCIENCES
2021
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up
JOURNAL OF NEUROLOGY
2021
A 5-year clinical follow-up study from the Italian National Registry for FSHD
JOURNAL OF NEUROLOGY
2021
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
NEUROLOGY
2021
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy
ORPHANET JOURNAL OF RARE DISEASES
2021
ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country
GENES
2021
The neurophysiological lesson from the Italian CIDP database
NEUROLOGICAL SCIENCES
2021
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP
JOURNAL OF NEUROLOGY
2021
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation
NEUROLOGICAL SCIENCES
2021
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial
LANCET NEUROLOGY
2021
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis
CELLS
2021
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome. An international observational study
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY
2021
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP
NEUROLOGICAL SCIENCES
2021
The unfolded protein response in amyotrophic later sclerosis. results of a phase 2 trial
BRAIN
2021
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials
EUROPEAN JOURNAL OF NEUROLOGY
2021
Immune-mediated necrotizing myopathy (IMNM): a myopathological challenge
AUTOIMMUNITY REVIEWS
2021
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study
MUSCLE & NERVE
2021
« prima
< precedente
1
2
3
4
5
6
seguente ›
ultima »
Progetti di Ricerca
Hepatitis E Virus (HEV) infection and facial nerve palsy: a prospective study
RM muscolare nella Distrofia Miotonica di tipo 1 (DM1)
Identificazione di nuovi biomarcatori radiologici del danno muscolare nelle miopatie genetiche e acquisite
Valutazione dei disturbi dell'equilibrio mediante posturografia statica in pazienti affetti da Distrofia Miotonica di tipo 1 (DM1)
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma